Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells ; volume:3 ; number:1 ; day:28 ; month:1 ; year:2005 ; pages:1-10 ; date:12.2005
Journal of translational medicine ; 3, Heft 1 (28.1.2005), 1-10, 12.2005
- Urheber
-
Akiyama, Yasuto
- Beteiligte Personen und Organisationen
-
Tanosaki, Ryuji
Inoue, Naoki
Shimada, Makiko
Hotate, Yukie
Yamamoto, Akifumi
Yamazaki, Naoya
Kawashima, Ichirō
Nukaya, Ikuei
Takesako, Kazutoh
Maruyama, Kouji
Takaue, Yoichi
Yamaguchi, Ken
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-3-4
- URN
-
urn:nbn:de:1111-2016041430683
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Akiyama, Yasuto
- Tanosaki, Ryuji
- Inoue, Naoki
- Shimada, Makiko
- Hotate, Yukie
- Yamamoto, Akifumi
- Yamazaki, Naoya
- Kawashima, Ichirō
- Nukaya, Ikuei
- Takesako, Kazutoh
- Maruyama, Kouji
- Takaue, Yoichi
- Yamaguchi, Ken
- SpringerLink (Online service)
Ähnliche Objekte (12)
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Novel treatment paradigms for metastatic uveal melanoma
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Novel treatment paradigms for metastatic uveal melanoma
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Novel treatment paradigms for metastatic uveal melanoma
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
Improved dendritic cell vaccination for combined melanoma immune therapy